- ¥367bn
- ¥373bn
- ¥163bn
- 87
- 43
- 91
- 87
Annual income statement for Organo, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Tanshin |
Standards: | JAS | JAS | JAS | JAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 100,638 | 112,069 | 132,426 | 150,356 | 163,269 |
Cost of Revenue | |||||
Gross Profit | 26,327 | 28,513 | 34,977 | 43,842 | 55,182 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 91,285 | 101,334 | 117,243 | 127,809 | 132,158 |
Operating Profit | 9,353 | 10,735 | 15,183 | 22,547 | 31,111 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 9,695 | 12,696 | 16,035 | 23,633 | 32,358 |
Provision for Income Taxes | |||||
Net Income After Taxes | 7,087 | 9,226 | 11,765 | 17,335 | 24,187 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 7,075 | 9,211 | 11,731 | 17,311 | 24,151 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 7,074 | 9,210 | 11,730 | 17,310 | 24,150 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 158 | 184 | 256 | 377 | 525 |
Dividends per Share |